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May you grow up to be righteous 
May you grow up to be true 
May you always know the truth 
And see the lights surrounding you 
 
May you always be courageous 
Stand upright and be strong 
May you stay 
May you stay forever young 
  
Introduction 
Evolution of human beings as super-organisms is the result of a mutualistic 
relationship with the huge microbial community residing in the human 
gastrointestinal (GI) tract, which is better known as the human gut microbiota 
(GM) 
1,2
.  
GM is made of a huge number of diverse microbial species. Recently, an 
integrated catalogue of the human faecal microbial metagenome, including 
almost 9.9 million microbial genes 
3
, has been created by combining data from 
1200 subjects in the United States, Europe and China 
4,5
. This reference catalogue 
can be accessed freely online (http://meta.genomics.cn) and represents a 
fundamental resource for further investigation over human GM. 
GM of healthy adults is highly resilient and stable over time. In adult life, GM 
reaches a state of homeostasis, which is the ability of the microbial ecosystem to 
maintain a fluctuating equilibrium among bacterial communities, the gut, and 
the immune system of the host 
6
. 
Imbalances in the composition and function of GM, also known as GM dysbiosis, 
have been linked to a large number of diseases: actually, GM has been 
recognized to influence several biological processes, such as immune maturation 
and homeostasis, host cell proliferation, vascularisation, neurologic signalling, 
pathogen burden, gut endocrine function, bone mineralization and energy 
biogenesis. In addition, human GM is involved in the biosynthesis of vitamins, 
steroid hormones and neurotransmitters, and in the metabolism of aminoacids, 
dietary components, bile salts, drugs and xenobiotics 
7
. Finally, the shaping of 
human GM during the whole lifespan has been proposed as a potential 
determinant of healthy aging 
8
. 
GM of each individual acquires its final and unique structural and functional 
layout through a complex process which begins in utero and reaches its climax in 
infancy 
9
, when infants are exposed to several external factors which modify 
profoundly their GM. From early childhood, the rapid rate of expansion in 
bacterial diversity observed during the first year of life slows down and GM 
gradually acquires its adult shape (Figure 1). Specifically, during toddlerhood, the 
introduction of complementary feeding and the maturation of the immune 
system start to shape GM towards its adult profile, which is further influenced, 
but to a lesser extent, by hormonal and sexual development, social behaviour, 
and adult-like diet and lifestyle during childhood and adolescence 
10
. 
 
Figure 1. Temporal development of gut microbiota in humans 
7
. 
 
 
Changes in GM along the course of human life are age-specific, as they are aimed 
at providing the host with an ecosystem finely calibrated for each stage of life 
(Figure 2) 
1,11
.  
 
Figure 2. Trajectory of gut microbiota development from birth to adult life 
11
. 
HMOs = human milk oligosaccharides; NDPs = non-digestible polysaccharides. 
 
 
Maternal influences on GM 
The infant GM is highly dependent from maternal influences, such as maternal 
genetics, environmental exposure, and diet before and during pregnancy, as well 
as during breastfeeding 
12
.  
Recent data confirm that bacterial colonization of the human gut begins well 
before birth: several studies have now demonstrated the presence of bacteria, 
during healthy pregnancies, in placental tissue, cord blood, amniotic fluid, foetal 
membranes and meconium 
13–16
. 
Actually, our understanding of the shaping of human GM has been recently 
revolutionized by the introduction of culture-independent molecular assays 
aimed at detecting and classifying GM and at characterizing its genes and gene 
products (Figure 3 
7
). 
 
Figure 3. Culture-independent tools for analyzing microbiota 
7
 
 
 
The introduction of these techniques has allowed to recognize that many infants 
are already exposed to microbes via a non-sterile amniotic fluid 
17,18
: this results 
in bacterial colonization of the foetal gut, as demonstrated by microbial DNA 
found in the meconium of preterm infants 
19
 and by the similarities in microbiota 
profile observed between the amniotic fluid and the meconium itself 
20
. 
Recently, a placental-specific microbiome profile has also been characterized 
13
, 
suggesting that the placenta may serve as an antenatal source of commensal 
bacteria for the infant. It is also plausible that length of gestation influences the 
quality and quantity of bacteria which are transferred from the mother to the 
foetus, contributing since before birth to differences in microbiota profiles 
between term and preterm infants 
21
. 
 
Mode of delivery 
A recent study performed in healthy term infants (TIs) who were followed up 
during the first year of life has confirmed that mode of delivery and feeding 
patterns have a dominant role in driving the assembly of the adult-like GM 
9
.  
GM in healthy infants born to vaginal delivery (VD) is built up through the oral 
inoculation of bacteria from the vagina and the maternal gut during labour and 
delivery. GM of these infants at birth is thus dominated by Lactobacillus and 
Prevotella. On the contrary, the acquisition of GM in infants born to caesarean 
section (CS) occurs later, is dependent from environmental sources (such as 
maternal skin) and is characterized by a lower diversity and by different bacteria 
(Staphylococcus, Corynebacterium e Propionibacterium) 
6,22,23
. The differences in 
GM composition are more pronounced for infants born to elective CS compared 
to those born to in-labour CS 
24
 and apparently persist through childhood 
25,26
. A 
low diversity in GM, such as that seen in infants born to CS, has been linked to an 
increased risk of several diseases, including late-onset sepsis 
27
 and necrotizing 
enterocolitis 
28
. In addition, the timing of colonization of the neonatal gut has 
been related in animal models to the ability to affect immune function 
12
.  
Further development of GM after birth is guided by a complex interaction 
between the microbiota itself, the host’s immune system and the environment. 
It is still unclear how this process exactly works, but several studies have shown a 
great inter-individual variability in composition and temporal patterns of GM 
establishment during the first year of life 
29
.  
Interestingly, gut colonization patterns established within the first week of life 
(guided by the so-called “pioneer bacteria” or “early settlers”) are believed to 
shape the composition of future GM 
30
. For this reason, all the events which 
occur during the first weeks/months of life are considered to be fundamental in 
laying the foundations for a healthy GM. 
Beyond intrauterine contamination and mode of delivery, feeding type, 
gestational age (GA) and antibiotic/probiotic use are considered the major 
determinants of GM in the neonatal period (Figure 4) 
6,26
.  
 
  
Figure 4. Impact of external factors on infant gut microbiota. Green arrows show 
beneficial modification; red arrows show modification considered as negative for 
healthy development 
6
. 
 
 
Feeding type 
Healthy TIs, who are born to VD and are exclusively breastfed, are thought to 
have the most beneficial GM composition. 
Human milk (HM) represents nature’s first functional food 
31
, as it provides a mix 
of nutrients, bacteria and functional compounds (such as oligosaccharides, 
proteins with antimicrobial activity, and fatty acids) which exert several biological 
functions, including the establishment of GM 
32,33
. 
According to recent data, the number of bacteria in HM is huge: in a recent 
study, HM median bacterial count was 10
6
 bacterial cells/ml 
34
. HM bacterial 
community contains over 350 prokaryotic genes, the dominant phyla being 
Proteobacteria and Firmicutes, and the most represented genera Pseudomonas, 
Staphylococcus and Streptococcus 
35
.  
The exact mechanism through which bacteria reach the mammary gland and are 
excreted into breast milk is still debated 
36
. One hypothesis is that HM mainly 
contains bacteria derived from the contamination with the mother’s skin and/or 
the infant’s mouth. The other hypothesis involves the so-called “entero-
mammary pathway” 
36,37
, according to which some bacteria could migrate from 
the maternal GI tract to the mammary gland during late gestation and lactation, 
through a mechanism involving gut monocytes. 
Facultative anaerobic or prevalently aerobic strains are among the most 
important components of HM microbiota, with a dominance of Streptococcus 
and Staphylococcus, together with skin-derived or environmental bacteria, such 
as Propionibacterium or species belonging to Enterobacteriaceae, and probiotic 
genera such as Bifidobacterium and Lactobacillus 
38
. Next generation sequencing 
also allowed the detection of obligate anaerobic, gut-associated genera, such as 
Bacteroides, Blautia, Dorea and Faecalibacterium 
39
, which, if alive, could act as 
pioneers in shaping the infant’s GM towards its adult profile. 
It is plausible that the infant’s mouth, being the transition point for HM to reach 
the GI tract, represents another fundamental actor in shaping GM features, both 
indirectly, through the contamination of HM, and directly through swallowing of 
saliva: the oral microbiota shows some peculiar characteristics, as it is usually 
dominated by Streptococcus and Staphylococcus in healthy breastfed TIs, while 
other bacterial taxa, such as Gemella, Actinomyces and Veillonella, represent 
minor colonizers 
40
.  
 
Figure 5. Potential sources of the bacteria present in human milk 
36
. 
 
Regardless their origin (Figure 5 
32
), HM bacteria and bioactive components 
confer to the infant’s GM several peculiar microbial features (high abundance of 
Bifidobacteria and Enterobacteria), which distinguish it from GM of formula-fed 
infants 
41
. Interestingly, even small amounts of formula given to breastfed infants 
appear to determine a shift in GM composition towards an “exclusive- formula” 
pattern 
42
, which is characterized by higher diversity and higher representation of 
bacteria such as Escherichia coli, Clostridium difficile, Bacteroides, Prevotella and 
Lactobacillus species.  
 
Preterm birth 
Preterm birth constitutes a challenge for both obstetricians and neonatologists. 
Multiple mechanisms are thought to lead to spontaneous preterm birth but, 
despite this, its exact trigger remains unknown in at least half of the cases. For 
this reason, prevention of spontaneous preterm labour and accurate 
management of preterm infants at and after birth represent a clinical and 
research priority.  
Preterm birth can be the result of maternal microbial dysbiosis and infection; 
furthermore, due to intrinsic immaturity and environmental factors, preterm 
infants always experience a certain grade of dysbiosis which appear to be 
dependent upon GA and clinical conditions (Figure 6 
43
). 
 
  
Figure 6. Overview of environmental factors that may condition the 
establishment of gut microbiota (GM) in preterm infants, including maternal 
factors during pregnancy (A), post-partum (B), and hospital-related factors 
known to affect neonatal GM establishment during the first weeks of life. Stars 
represent the stages when dietary strategies for GM modulation are feasible 
43
. 
HPA = hypothalamic-pituitary-adrenal; NEC = necrotizing enterocolitis; NICU = 
neonatal intensive care unit. 
 
 
The most immature is the infant and the most severe are his/her clinical 
conditions, the most disrupted his/her GM will be compared to the GM of a 
healthy TI. This comparison is particularly relevant as we know that preterm 
infants are exposed during the early stages of their lives to a series of medical 
interventions which can impact on their short and long-term health status. In this 
perspective, all the interventions which interfere with the establishment of a 
healthy GM can further impair the already unstable clinical conditions of these 
infants, leading to serious medical complications such as necrotizing enterocolitis 
and sepsis. On the other side, improving the knowledge of the features of 
dysbiosis associated with preterm birth can help in identifying potential 
interventions aimed at restoring GM equilibrium (Figure 7 
43
), in order to 
improve these infants’ clinical outcome.  
 
Figure 7. Differences in gut microbiota between preterm and healthy term 
infants, and health consequences of dysbiosis at intestinal and systemic level. 
(a) Environmental factors conditioning variations in gut microbiota 
composition and health consequences at intestinal (NEC) and systemic 
level (cognitive and systemic problems, and sepsis). 
(b) Environmental and nutritional strategies with potential to modulate 
preterm gut microbiota. 
HMO = HM oligosaccharides; KMC = kangaroo mother care; NEC = necrotizing 
enterocolitis; SCFA = short-chain fatty acids. 
 
 
It has been shown that in preterm infants, compared to term babies, gut 
colonization is delayed, bacterial diversity is generally low, and there is a 
considerable individual variation in bacterial composition. Preterm GM is 
generally characterized by an increased number of Enterobacteriaceae (including 
E. Coli, Klebsiella, Enterobacter), Enterococcaceae, Lactobacillaceae and 
Staphylococcaceae, and a lower and delayed representation of 
Bifidobacteriaceae. This abnormal intestinal colonization may alter the barrier, 
nutritional and immunological functions of the host-microbiota relationship, thus 
increasing susceptibility to disease 
44–46
.  
Despite growing literature about GM features in very (<32 weeks GA) and 
extremely (<28 weeks GA) preterm infants, little is still known about infants who 
are born at 32-34 and 35-36 weeks gestation, who are respectively defined as 
“moderately” and “late” preterm infants. Even if they have a much lower risk of 
medical complications than more premature infants, they still experience, 
compared to full TIs, higher rates of infant morbidity and mortality, as well as 
higher risks of childhood disabilities 
47
. 
When preterm birth occurs at 32-36 weeks gestation, it interrupts physiological 
development of pulmonary and gastrointestinal functions 
48
. Moderately and 
late preterm infants experience a delay in the full establishment of coordinated 
latch, suckling, swallowing and breathing 
49
, incomplete oesophageal peristalsis 
50
, and altered gastric emptying 
51
. The achievement of these developmental 
milestones is essential for establishing complete feeding tolerance and satisfying 
the high nutritional needs of the growing preterm infant. In addition, impairment 
in GI function, as well as difficulties in achieving compete and exclusive 
breastfeeding 
52
, have the potential to impair the establishment of a healthy GM. 
The features of GM in moderately preterm infants (MPIs) have been investigated 
in few studies, which have led to inconclusive results. In this context, it has been 
suggested that gut colonization with Bifidobacteriaceae 
53
 does not begin before 
33 weeks gestation, that the relative abundance of these bacteria is low and GM 
is dominated by members of the Enterobacteriaceae, similarly to preterm infants 
of lower GA 
54
.  
 
  
Antibiotics and probiotics 
The use of prenatal and neonatal antibiotics has been linked in several studies to 
the disruption of GM. Antibiotics given to the mother during the last trimester of 
pregnancy, during CS, and/or during breastfeeding have been linked to neonatal 
GM dysbiosis 
55
. In addition, the use of intrapartum antibiotic prophylaxis for 
maternal group B Streptococcus infection has been shown to modify GM in 
otherwise healthy TIs 
56
. Similarly, the use of antibiotics during the neonatal 
period is considered one of the main interventions which could affect negatively 
GM, especially in preterm infants 
57
. In this perspective, growing literature is 
attempting to identify preventive interventions, such as the use of probiotics 
58–
60
, prebiotics 
61
 and functional nutrients 
62
, aimed at restoring a healthy profile of 
GM. 
 
Aims of the study 
The present research project was developed in order to add further knowledge 
regarding the mechanisms guiding the establishment of GM in term and preterm 
infants. Specifically, the aim of the study was to characterize the establishment 
of GM, in relation to the microbiota of saliva and mother’s milk, in term and 
preterm infants, with a focus on GM features in moderately preterm infants. 
 
 
  
Methods 
Study details and ethics 
The study was conducted in collaboration with the Department of Pharmacy and 
Biotechnology of the University of Bologna and is part of the Cluster Research 
Project named PROSIT (“PROmozione della Salute del consumatore: 
valorizzazione nutrizionale dei prodotti agroalimentari della tradizione ITaliana” 
– study code CTN01_00230_413096). 
The study protocol was approved by the independent Ethical Committee of 
Sant’Orsola-Malpighi Hospital (study IDs: 25/2014/U/OSS and 53/2014/U/Tess). 
For each enrolled infant, parents and/or legal guardians were asked to provide a 
written informed consent before entering the study protocol. 
 
Patients 
Newborns were recruited at the Neonatal Unit of Sant’Orsola-Malpighi Hospital 
(AOU Bologna), if fulfilling the following characteristics: 
• Group A: TIs (GA ≥37 weeks), born to VD, and exclusively breastfed, who 
were not exposed to any antibiotic/probiotic before, during and after 
delivery. Infants who developed any medical condition requiring hospital 
admission were excluded from the study. 
• Group B: MPIs (GA 32 – 34
+6
 weeks) who were admitted to the Neonatal 
Intensive Care Unit (NICU). 
• Group C: very preterm infants (GA <32 weeks) and/or very low birth 
weight (VLBW) infants (birth weight [BW] <1500 g) who were admitted to 
the NICU. 
Each infant/mother pair’s demographic and clinical characteristics were collected 
in a specific case report form. 
 
  
Sample collection 
For each infant/mother pair, the following biological samples were collected: 
Group A 
At 20 days of life (DOL): 
• Infant stools 
• Own mother’s milk (OMM) 
• Neonatal oral swabs, pre and post breastfeeding 
Group B 
At DOL 1, 2-4, 7, 14, 21, and, after that, once each month until the introduction 
of complementary feeding: 
• Infant stools 
• OMM, when available 
• Neonatal oral swab 
Additional samples were collected at the beginning of breastfeeding: 
•  Infant stools 
• OMM 
• Two neonatal oral swabs (before and after the infant’s contact with the 
breast) 
Group C 
At DOL 1, 2-4, 7, 14, 30, and, after that, once each month until 3 months term-
equivalent age (which roughly corresponds to the timing of the introduction of 
complementary feeding in these patients): 
• Infant stools 
• OMM, when available 
 
Regardless study group, sample collection methods were the following: 
• Stools were collected directly from diapers and immediately placed into 
sterile plastic tubes. 
• OMM was collected with the aid of a breast pump into sterile plastic 
tubes; prior to collection, mothers were asked to wash the nipple and 
mammary areola with soap and water. 
• Oral samples were obtained by gently swabbing a sterile cotton-tipped 
applicator on the inside of the infant’s cheek.  
All the samples were delivered promptly to the Laboratory at the Department of 
Pharmacy and Biotechnology of the University of Bologna for the analyses.  
 
Microbiota analyses (from Biagi E, Quercia S, Aceti A et al. Bacterial sharing 
between the ecosystems of mother’s milk and infant’s mouth and gut. Submitted 
to Frontiers in Microbiology – March 2017) 
 
1. Total bacterial DNA extraction 
Total bacterial DNA was extracted from stools using the DNeasy Blood & Tissue 
Kit (QIAGEN, 273 Hilden, Germany) with a modified protocol, as previously 
described 
8
. Two-hundred-fifty mg of stools were resuspended in 1 ml of lysis 
buffer (500mM NaCl, 50 mM Tris–HCl pH 8, 50 mM EDTA and 4% SDS) and 
treated with 3 bead-beating steps in a Fast Prep instrument (MP Biomedicals, 
Irvine, CA) at 5.5 movements per sec for 1 min. Samples were then heated at 
95°C for 15 min. Solid particles were centrifuged at full speed for 5 min at 4°C, 
then 260 μl of 10M ammonium acetate were added and the samples incubated 
for 5 min in ice. Debris was pelleted by 10 min of centrifugation at full speed at 
4°C, the supernatants were collected and 1 volume of isopropanol was added. 
Samples were incubated in ice for 30 min. DNA was collected by 15 min of 
centrifugation at full speed at 4°C and the pellet washed with 70% ethanol. The 
pellet was then dissolved in 100 μl of TE buffer and treated with 2 μl of DNase-
free RNase (10 mg/ml) for 15 min at 37°C. After incubation, 200 μl of AL buffer 
(QIAGEN) and 15 μl of proteinase K were added and heated at 70°C for 10 min. 
DNA was further purified using QIAamp Mini Spin columns (QIAGEN) following 
the manufacturer’s instructions. 
For HM samples, 2 ml of HM were centrifuged at full speed for 10 min at 4°C and 
then the same protocol described for stool samples was applied. 
For oral swabs, the cotton swab was suspended in 500 μl of PBS, vortexed for 1 
min and sonicated for 2 min. These 2 steps were repeated twice, and then 2 
cycles of bead-beating with FastPrep at 5.5 movements per sec for 1 min, with 
200 mg of glass beads, were applied. Cotton residues were removed and the 
debris pelleted by centrifugation at 9000 g for 5 min. The supernatant was 
discarded and the pellet resuspended in 180 μl of enzymatic lysis buffer 
(QIAGEN). Samples were then treated according to the DNeasy Blood&Tissue kit 
(QIAGEN) instructions, following the protocol for Gram positive bacteria. 
Extracted DNAs were quantified using the NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE). 
 
2. 16 rRNA gene amplification and sequencing. 
For each sample, the V3-V4 region of the 16S rRNA gene was PCR amplified in 25 
μl final volume containing 5 μl of microbial DNA (diluted to 5 ng/μl for faecal 
samples, undiluted for milk and oral swab), 2X KAPA HiFi HotStart ReadyMix 
(KAPA Biosystems, Resnova, Rome, Italy), and 200 nM of S-D-Bact-0341-b-S-17/S-
D-Bact-0785-a-A-21 primers carrying Illumina overhang adapter sequences. 
Thermocycler was programmed as follows: initial denaturation at 95°C for 3 min, 
25 cycles of denaturation at 95°C for 30 sec, annealing at 55°C for 30 sec, and 
extension at 72°C for 30 sec, and a final extension step at 72°C for 5 min 
8
. 
Amplicons of about 460 bp were purified with a magnetic bead-based clean-up 
system (Agencourt AMPure XP; Beckman Coulter, Brea, CA) and sequenced on 
Illumina MiSeq platform using a 2×300 bp paired end protocol, according to the 
manufacturer’s instructions (Illumina, San Diego, CA). Briefly, indexed libraries 
were prepared by limited-cycle PCR using Nextera technology and further 
cleaned up with AMPure XP magnetic beads (Beckman Coulter). Libraries were 
pooled at equimolar concentrations (4nM), denatured and diluted to 6 pM 
before loading onto the MiSeq flow cell. 
Bioinformatics and statistics 
Raw sequences were processed using a pipeline combining PANDAseq 
63
 and 
QIIME 
64
. Sequencing reads were deposited in the National Center for 
Biotechnology Information Sequence Read Archive (NCBI SRA; BioProject ID 
PRJNA378341). High-quality reads were binned into operational taxonomic units 
(OTUs) according to the taxonomic threshold of 97% using UCLUST 
65
. Taxonomy 
was assigned using the RDP classifier against Greengenes database (May 2013 
release). Chimera filtering was performed by discarding all singleton OTUs. Alpha 
rarefaction was analyzed by using Chao1, PD whole tree, observed species, and 
Shannon index metrics. Beta diversity was estimated by computing weighted and 
unweighted UniFrac distances. 
Statistics was performed using R software (https://www.r-project.org/) and the 
libraries vegan and made4. Weighted and unweighted UniFrac distances were 
used for Principal Coordinates Analyses (PCoA), and the significance of 
separation was tested by permutational multivariate analysis of variance using 
the function “adonis” of the vegan package. Alpha diversity was quantified by 
computing the Simpson diversity index (SDI) using the function “diversity” of the 
vegan package and the normalized OTU counts for each sample. Mann-Whitney 
U test was used to assess significant differences between groups of samples. P 
values were corrected for multiple comparisons using the Benjamini-Hochberg 
method. P<0.05 was considered as statistically significant. Correlation between 
datasets was tested by using the Kendall method. 
 
  
Results 
Patients’ recruitment 
During the study period, eighty-one infants and their mothers were enrolled in 
the study: 
• Thirty-six in Group A (TIs) 
• Fifteen in Group B (MPIs), for whom a faecal sample obtained at DOL 21 
was available. Among them, complete longitudinal data (stools, HM, and 
saliva) of 7 infants were also evaluated (microbiota analysis of the 
remaining infants is ongoing). 
• Thirty in Group C (very preterm and/or VLBW infants). Sample collection 
in this group is ongoing. 
 
Group A 
All the infants were born to VD, and had not been exposed to any 
antibiotic/probiotic before, during or after delivery. All of them had been 
exclusively breastfed since birth. Mean GA was 39
+5
 (range 37-41
+4
), with a BW 
ranging from 2530 to 4090 g. 
The following samples were collected at DOL 20:  
• 36 OMM samples. 
• 36 infants’ stool samples. 
• 71 infants’ oral swabs (35 pairs of samples pre and post-breastfeeding, 
and 1 unpaired pre-breastfeeding sample). 
 
Group B 
The 15 infants belonging to this group were born at a mean GA of 33
+2
 weeks 
(range 32-34
+6
), with a BW ranging from 1210 to 2310 g. There were 9 twins and 
6 singleton infants. All of them, except one, were born to CS, and all the mothers 
had received antibiotics before or during delivery. All the infants were admitted 
to the NICU at birth. Twelve of them received antibiotic treatment with ampicillin 
during the first days of life. 
As for feeding, 6 infants were fed exclusive HM (4 infants were fed OMM, while a 
couple of twins received exclusive donor milk). Two infants received exclusively 
formula, and the remaining 8 received mixed feeding (HM + formula). Nine 
infants started breastfeeding during the study period, at a mean age of 14 days 
of life (range 7-21 days). 
For each infant, a stool sample collected at DOL 21 was analyzed for comparison 
with TIs GM. 
In addition, for the 7 infants whose longitudinal data were complete (P11, 12, 21, 
22, 31, 32, 40), the following samples were analyzed: 
• 22 OMM samples. 
• 48 infants’ stool samples. 
• 57 infants’ oral swabs. 
 
  
Microbiota analysis 
Group A  
Stools 
Faecal microbiota of healthy TIs (Figure 8) was largely dominated by members of 
the family Bifidobacteriaceae (average relative abundance [ARA] 38.3%), 
followed by Enterobacteriaceae (ARA 15.4%), Streptococcaceae (ARA 13.9%), 
Bacteroidaceae (ARA 9.6%), Staphylococcaceae (ARA 5.4%), and Lactobacillaceae 
(ARA 4.8%). Bifidobacterium represented the dominant genus in 67% of samples. 
 
Figure 8. Relative abundances of different microbial families found in the stools 
of term infants. 
 
 
Mother’s milk 
Streptococcaceae, which are peculiar of HM, were the most represented 
bacterial family (ARA 24.5%); in addition, a discrete representation of 
Bifidobacteriaceae (ARA 11.5%), which are common in infants’ stools, and 
Staphylococcaceae (ARA 11.1%), which are instead common skin and mouth 
inhabitants, was found in HM. Furthermore, HM contained some anaerobic 
bacterial families which are usually found in the adult GI tract, such as 
Lachnospiraceae (ARA 10.3%), Ruminococcaceae (ARA 5.4%), and Bacteroidaceae 
(ARA 4.4%).  
 
Saliva 
Microbiota from oral swabs was largely dominated by the family 
Streptococcaceae (ARA 69.8%), with Streptococcus being the dominant genus in 
94% of the samples. 
 
Relationship among the three microbial ecosystems 
As shown in Figure 9, microbiota from infant’s saliva, infant’s stools and mother’s 
milk clustered separately, as can be expected since the three body sites are 
different in terms of pH, oxygen status, and nutrients availability. 
 
Figure 9. PCoA based on unweighted UniFrac distances of the microbiota of 
mother’s milk (light blue), infant stools (yellow), and infants mouth (pink).  
 
SDI was calculated for each ecosystem (Figure 10
significantly more diverse (SDI 0.88
(p<0.0001 for both comparisons
 
Figure 10. Simpson diversity index for each ecosystem: human milk (blue), infant 
stools (yellow), and infant saliva (pink). 
 
Within-samples variability of HM was 
according to both unweighted
weighted (0.25 ± 0.07
comparisons), meaning 
of bacterial species than GM
Saliva unweighted UniFrac 
however, when the weighted UniFrac distances were calculated, 
the lowest within-samples variability (0.14
between oral samples resided in the subdom
fraction of the ecosystem.
In order to explore potential migration patterns from one ecosystem to 
others, the characteristics of 
were evaluated, taking into account only OTUs 
of the ecosystem diversity.
): HM microbiome was 
 ± 0.11) than both faecal and oral 
). 
 
lower compared to those of 
 (0.68 ± 0.03 vs. 0.80 ± 0.04, respectively
 vs. 0.50 ± 0.20) UniFrac metric (p<0.0001 for both 
that HM microbiota was more “homogeneous” in terms 
.  
distances (0.80 ± 0.03) were as high as 
 ± 0.06), suggesting that the variability 
inant, non-Streptococcaceae 
  
the OTUs shared between at least two ecosystems 
which accounted for at least 0.1% 
 
microbiome 
 
faecal samples 
) and 
faecal ones; 
saliva showed 
the 
OTUs assigned to Staphylococcus spp. were shared by the three ecosystems in 
80% (pre breastfeeding) and 83% (post breastfeeding) of cases, and by stools and 
milk in 91% of cases. OTUs assigned to Streptococcus spp. were shared by the 
three ecosystems in more than 80% of cases, and by stools and saliva in 86% (pre 
breastfeeding) to 91% (post breastfeeding) of cases. Streptococcus infantis was 
shared between stools and HM in almost all the cases (97%), and by the three 
ecosystems in 63% of cases. Quite interestingly, the Streptococcus OTUs shared 
between two or three ecosystems were also those which were dominant in the 
saliva microbiota.  
HM and infant’s saliva shared an OTU assigned to unclassified members of the 
family Gemellaceae in 51% of cases. In addition, the majority of OTUs shared 
between HM and stools belonged to the Bifidobacterium genus: Bifidobacterium 
breve (46%), Bifidobacterium bifidum (51%), and Bifidobacterium longum (74%). 
On the contrary, Bifidobacteria were almost absent in the oral ecosystem (ARA 
0.4%). 
 
Group B 
Stools – DOL 21 evaluation and comparison with term infants 
Data from 15 MPIs were evaluated and compared with data from the 36 TIs. 
At DOL 21, faecal microbiota of MPIs (Figure 11) was largely dominated by 
members of the family Enterobacteriaceae, followed by Bifidobacteriaceae. 
Compared to TIs (Table A), there was a similar ARA of Streptococcaceae and 
Staphylococcaceae, slightly lower ARA of Lactobacillaceae, and higher ARA of 
Clostridiaceae and Veillonellaceae. Bacteroidaceae were almost absent in the 
stools of MPIs.  
Both in term and preterm infants’ stools, there was a high interindividual 
variability in the proportion of the eight most abundant bacterial families (Table 
A - Figure 12-13).  
 
  
Figure 11. Relative abundances of different microbial families found in the stools 
of moderately preterm infants. 
 
 
Table A. Average relative abundance (range) of the most represented bacterial 
families in stools of term and moderately preterm infants at 20-21 days of life. 
 Preterm infants Term infants 
Enterobacteriaceae 36% (0.1-80.6) 15.4% (0.01-60) 
Bifidobacteriaceae 20% (0.04-41.3) 38.3% (0.03-90.3) 
Streptococcaceae 16% (1.6-54.1) 13.9% (0.02-39.9) 
Staphylococcaceae 5% (0-19.2) 5.4% (0-20.9) 
Lactobacillaceae 3.1% (0.02-16.3) 4.8% (0-33.7) 
Clostridiaceae 4.9% (0.05-26.4) 1.6% (0-21.3) 
Veillonellaceae 5.3% (0-36.5) 2.9% (0-27.5) 
Bacteroidaceae 0.02% (0-0.2) 9.6% (0-45.4) 
 
Figure 12. Proportion of the eight most abundant bacterial families in gut 
microbiota for each term infant. 
 
 
Figure 13. Proportion of the eight most abundant bacterial families in gut 
microbiota for each moderately preterm infant. 
 
 
  
Mother’s milk 
Longitudinal data from 7 patients and their mothers were examined.  
HM samples were available for two mothers (the mother of a couple of twins 
[M20] and the mother of a singleton baby [M40]). The remaining two mothers of 
two twin couples [M10 and M30] were unable to provide a complete set of HM 
for study purposes, due to a reduced milk production over time. 
Regardless sampling time, HM microbiota of mothers of MPIs was quite different 
compared to that of TIs, as it was largely dominated by members of the family 
Staphylococcaceae (ARA 28.2%), followed by Streptococcaceae (ARA 19.02%) 
and Enterococcaceae (ARA 5.6%). The average abundance of Bifidobacteriaceae 
was much lower than in HM from mothers of TIs (ARA 4 vs. 11.5%). On the 
contrary, a discrete amount of members of the family Corynebacteriaceae (ARA 
3.7%) was found in MPIs’ HM.  
MPIs’ HM also contained adult gut-specific bacterial families, but in lower 
proportion compared to term HM (Lachnospiraceae: ARA 3.9 vs. 10.3%; 
Ruminococcaceae: ARA 2.7 vs. 5.4%; Bacteroidaceae: ARA 1.6 vs. 4.4%).  
 
Saliva 
Oral swabs data were available for all the infants. Regardless sampling time, the 
characteristics of microbiota in MPIs saliva were similar to those of TIs, with a 
dominance of Streptococcaceae (ARA 59.1%), followed by Micrococcaceae (ARA 
9.7%), Pseudomonadaceae (ARA 7.7%), and Staphylococcaceae (ARA 5.2%). 
However, it is interesting to note that the abundance of Streptococcaceae was 
very low on DOL 1 (ARA 4.8%), but their dominance of the infant’s saliva 
microbiota was already established by DOL 4 (ARA 55.4%) or DOL 7 (ARA 68.2%). 
Distribution of the abundance of Micrococcaceae was also peculiar, as almost all 
the infants had a low abundance of Micrococcaceae at birth, followed by a 
sudden but transient increase over time. 
 
 
Establishment of GM in MPIs – Relationship with microbiota in HM and saliva 
For graphical purposes, the analysis of longitudinal data was restricted to the 
twelve most abundant bacterial families (see Table B). 
 
Table B. Bacterial families which the highest average relative abundances in 
stools, human milk, and saliva. 
Stools Mother’s milk Saliva 
Enterobacteriaceae Staphylococcaceae Streptococcaceae 
Bifidobacteriaceae Streptococcaceae Micrococcaceae 
Streptococcaceae Enterococcaceae Pseudomonadaceae  
Staphylococcaceae Bifidobacteriaceae Staphylococcaceae 
Lactobacillaceae Lachnospiraceae  
Clostridiaceae Corynebacterium  
Veillonellaceae   
 
Longitudinal data regarding human milk from single mothers showed some 
peculiar changes through the course of lactation. Two sets of HM were 
evaluated; one from the mother of a couple of twins (M20, Figure 14), and the 
other from the mother of a singleton baby (M40, Figure 15).  
 
  
Figure 14. Longitudinal data of human milk microbiota from the mother of a 
couple of moderately preterm twins (M20 – P21 and P22; x axis shows days of 
life, y axis represents relative abundance of bacterial families).  
 
 
Figure 15. Longitudinal data of human milk microbiota from the mother of a 
singleton moderately preterm infant (M40 – P40; x axis shows days of life, y axis 
represents relative abundance of bacterial families).  
 
 
Both HM sets showed an initial prevalence of Staphylococcaceae, whose relative 
abundance tended to diminish during the course of lactation. On the other side, 
the relative abundance of Streptococcaceae tended to increase over time, 
especially for M20. Both these changes seemed to begin in conjunction with the 
first contact of the infants with their mother’s breast (DOL 21 for one of the 
twins, between DOL 7 and 14 for the singleton baby). The proportion of 
Bifidobacteriaceae in both sets remained very low during the entire course of 
lactation.  
The two HM sets also showed some peculiar differences: HM from M20 had a 
discrete proportion of Micrococcaceae, which increased after DOL 30, and which 
were present only in very small amounts in HM from M40. On the contrary, HM 
from M40 showed a sudden increase in the proportion of Enterococcaceae from 
DOL 60; Enterococcaceae were almost absent in HM from M20. 
Figure 16 represents PCoA based on unweighted and weighted UniFrac distances 
of microbiota of the two HM sets (M20 and M40) over time, while Figure 17 
focuses on HM samples taken from M40. It is interesting to note how HM 
microbiota at various time points clusters in both unweighted and weighted 
analyses: all the HM samples taken from DOL 60 onwards tend to cluster 
together in both analyses, with no apparent relationship with samples taken 
previously. The only exception is the 150-DOL sample, which is distant from the 
others in the weighted analysis. This is due to a transient but significant change 
in HM microbiota at DOL 150 compared to previous and later ones, characterized 
by a much higher proportion of Staphylococcaceae and a much lower proportion 
of Streptococcaceae. 
  
  
Figure 16. PCoA based on unweighted and weighted UniFrac distances of 
microbiota of two human milk sets (M20 and M40) over time. Symbols represent 
the two human milk sets, colours the different time points. 
 
 
  
Figure 17. PCoA based on unweighted and weighted UniFrac distances of 
microbiota of human milk from M40 over time. Symbols represent the two 
human milk sets, colours the different time points. 
 
 
Longitudinal data obtained from oral swabs were available for all the infants. The 
common tract among all of them was the very low proportion of 
Streptococcaceae on DOL 1, followed by a sudden and stable increase of these 
bacteria over time. Micrococcaceae were the second most abundant bacterial 
family in saliva: it is interesting to note that, in all the patients, the amount of 
Micrococcaceae in saliva increased after the first-second week of life, and 
decreased at DOL 150-210. The relationship between the amount of 
Micrococcaceae in HM and saliva was variable: the amount of Micrococcaceae in 
the saliva of P21 and P22 increased significantly since DOL 14-30 and, since DOL 
30, a sudden increase of these bacteria was documented also in the HM from 
their mother. P40 showed a similar increase in saliva Micrococcaceae since DOL 
7, but this was not linked to any increase of these bacteria in his mother’s milk. 
Individual patients’ samples showed some peculiar differences in the proportion 
of the other, subdominant bacterial families, which could not be attributable to 
any known clinical characteristic. Differences in saliva microbiota at a given 
sampling time were present also within twin couples (Figure 18). There were no 
apparent differences between samples taken immediately before and after the 
first contact of the infants with their mothers’ breast. 
Figure 19 represents PCoA based on unweighted and weighted UniFrac distances 
of saliva microbiota over time. As shown by green boxes, saliva microbiota 
clustered in a peculiar way on DOL 1 both in unweighted and weighted analysis. 
In addition, also the three samples taken on DOL 210 clustered together in the 
two analyses (red boxes). 
 
 
 
 
 
 
Figure 18. Longitudinal data of saliva microbiota from three infants (P21, P22, 
P40. x axis shows days of life, y axis represents relative abundance of bacterial 
families). 
 
Figure 19. PCoA based on unweighted and weighted UniFrac distances of saliva 
microbiota over time. Symbols’ colours represent the different time points (DOL-
1 samples are inside green boxes, DOL-210 samples inside red boxes). 
 
 
  
Stools 
Longitudinal data about GM were available for all the infants. P21, P22, and P40 
completed the longest follow up (from birth to DOL 210). 
There were some similarities and some remarkable differences among patients 
and also within twin couples.  
 
Twins P11 and P12 showed some differences in GM since DOL 1, which could not 
be linked to any clinical difference between the two infants: on DOL 4, P11 stools 
were abundant in Staphylococcaceae (84%), while stools of P12 were dominated 
by members of the family Oxalobacteraceae, and Staphylococcaceae 
represented less than 1% of the overall bacterial diversity (Figure 20). The 
relative abundance of Enterobacteriaceae was not very high (mean 21.5% over 
time in P11 and 22.5% over time in P12). 
Quite interestingly, the differences in GM between P11 and P12 reflected a 
different saliva microbiota on DOL 4: specifically, in P12, Staphylococcaceae 
represented only the 0.5% of the overall saliva microbiota, which was made 
almost exclusively by Pseudomonadaceae (48.3%), followed by 
Oxalobacteraceae (14.7%) and Paenibacillaceae (12.2%). The abundance of 
Streptococcaceae was very low (2%). On the contrary, in P11 on DOL 4 almost 
half of the saliva microbiota was already constituted by Streptococcaceae 
(48.4%), followed by a quite high proportion of Staphylococcaceae (42.9%). 
In both twins, a discrete amount of Bifidobacteriaceae (relative abundance 19-
25%) appeared in GM since DOL 14. Bifidobacteriaceae were almost absent in 
both twins’ saliva. Unfortunately, HM from the twins’ mother was not available 
for analysis; none of the twins had been in contact yet with their mother’s breast 
on DOL 14. 
 
  
Figure 20. Longitudinal development of gut microbiota diversity in two twins 
(P11 and P12; x axis shows days of life, y axis represents relative abundance of 
bacterial families). 
 
 
 
 
 
 
 
 
GM of another couple of twins (P31 and P32 - Figure 21) showed some peculiar 
differences compared to GM of P11 and P12, as it was largely dominated by 
Enterobacteriaceae in the first week of life (on DOL 7, 87.1% in P31 and 90.6% in 
P32). Similarly to P11 and P12, Bifidobacteriaceae appeared in a discrete amount 
since DOL 14 of life; both twins had started breastfeeding between DOL 7 and 14, 
but unfortunately the mother was unable to provide HM samples for analysis. 
Bifidobacteriaceae were almost absent in both twins’ saliva.  
GM of P31 and P32 was different in terms of relative abundance of 
Veillonellaceae (mean 10.2% in P31, 0.2% in P32) and Micrococcaceae (mean 
0.2% in P31, 3.1% in P32). Differences between the two twins could not be 
attributed to differences in saliva microbiota: relative abundance of 
Veillonellaceae was very low in both infants, and mean abundance of 
Micrococcaceae was similar (4.5% in P31, 2.4% in P32). 
 
  
Figure 21. Longitudinal development of gut microbiota diversity in two twins 
(P31 and P32; x axis shows days of life, y axis represents relative abundance of 
bacterial families). 
 
 
  
Other twins (P21 and P22) were quite similar in terms of developmental pattern 
of GM over time: similarly to P31 and P32, GM was dominated by 
Enterobacteriaceae in the first month of life; however, significant colonization 
with Bifidobacteriaceae did not occur before the second month of life (Figure 
22). In addition, GM of P21 and P12 appeared to be more diverse compared to 
GM of the previous two couples of twins, with several subdominant bacterial 
families reaching at least 3% mean relative abundance over time (P21: 
Enterococcaceae 9.1%, Streptococcaceae 7.3%, Lactobacillaceae 7.2%, 
Clostridiaceae 3.7%, Veillonellaceae 3.6%; P22: Enterococcaceae 10%, 
Clostridiaceae 7.9%, Streptococcaceae 5.3%, Lachnospiraceae 3.8%). Quite 
interestingly, despite the discrete amount of Micrococcaceae found in saliva and 
HM of the twins, the abundance of these bacteria in stools was extremely low for 
both of them. 
 
 
  
Figure 22. Longitudinal development of gut microbiota diversity in two twins 
(P21 and P22; x axis shows days of life, y axis represents relative abundance of 
bacterial families). 
 
 
P21 and P22, as well as P40, completed the longest follow up (from birth to DOL 
210): it is quite interesting to note that, in these three infants, intestinal 
dominance of Bifidobacteriaceae was established at very different time points 
(not before DOL 120 in the twins, and already by DOL 7 in P40 – Figure 23).  
 
  
Figure 23. Longitudinal development of gut microbiota diversity in a singleton 
infant (P40; x axis shows days of life, y axis represents relative abundance of 
bacterial families). 
 
 
Bacterial diversity of GM in P40 was peculiar, as GM was dominated by 
Bifidobacteriaceae since DOL 7 (mean 37.4% over time), followed by 
Streptococcaceae (24.7%), and Enterobacteriaceae (12.6%).  
Similarly to all the other MPIs, Bifidobacteriaceae were very low in HM from 
P40’s mother and almost absent in his saliva. The high proportion of 
Enterobacteriaceae in P40’s stools, especially since DOL 30, did not relate to a 
relevant abundance of these bacteria in HM or saliva. The proportion of 
Micrococcaceae in P40’s GM was very low, despite the high abundance in his 
saliva. 
  
Discussion 
The building of GM in both term and preterm infants is crucial to educate the 
infants’ immune system to the balance between tolerance and reactivity which is 
needed to maintain health through life 
7,66
. For this reason, adding further 
knowledge about how neonatal GM is shaped by the interaction with the mother 
and the environment would be extremely helpful in order to better define the 
influence of microbiota on neonatal outcome and thus to identify potential 
interventions aimed at limiting negative effects of dysbiosis in high-risk patients, 
such as preterm infants.  
Nutrition is known to strongly and directly affect clinical outcomes, both in term 
and preterm infants: as for term infants, several studies suggest a direct effect of 
breastfeeding on various aspects of neurological and white matter development 
67
. More importantly, HM feeding has been linked to improved clinical outcome 
68,69
, including better neurodevelopment 
70
, also in very preterm infants. 
During the neonatal period, nutrition represents one of the most important 
factors which guide the establishment of a healthy GM. It is well known that HM 
has its own peculiar microbiota, but the exact mechanism through which HM 
microbial diversity is built is still a matter of research: even if a controversial 
entero-mammary pathway has been proposed for some bacteria 
37
, it is plausible 
that HM microbiota is also subject to other environmental influences. 
According to the results of the present study, and in line with previous literature 
38
, HM produced by mothers of healthy term infants is characterized by a “core” 
of few bacterial families which represent at least half of the microbial community 
32,71,72
. The relative amount of these dominant bacterial families and the 
abundance of other bacteria vary across studies and could be dependent on 
geographical location 
73,74
. In the present study, HM microbiota showed a slight 
dominance of members of the family Streptococcaceae, followed by 
Bifidobacteriaceae and Staphylococcaceae, and by lower amounts of members of 
Lachnospiraceae, Ruminococcaceae and Bacteroidaceae. This composition of HM 
microbiota probably reflects different sources of colonization: the infant’s saliva 
during breastfeeding for Streptococcaceae, maternal skin and the environment 
for Staphylococcaceae, and maternal gut through the so-called entero-mammary 
pathway 
39
 for the last three bacterial families. 
As reported by previous studies, Bifidobacteriaceae are the most abundant 
bacterial family in healthy term infants’ GM, which is thus referred to as the 
“milk-oriented” microbiota 
75
. The origin of these bacteria in HM does not need 
to be necessarily attributed to a complex entero-mammary pathway 
37
; actually, 
recent observations suggest that each individual is surrounded by an unique 
microbial cloud, which could allow the migration of specific bacteria between 
different body sites and, possibly, different individuals 
76
. 
It is interesting to note that HM microbiota in term infants had the highest 
diversity compared to oral and gut microbiota, which means that HM microbiota 
was the richest among the three. However, within-samples variability of HM was 
lower compared to those of faecal samples, which also means that HM 
microbiota was more “homogeneous” in terms of bacterial species than GM. This 
observation suggests that the mammary gland might act as an environmental 
filter which allows survival and proliferation of a certain number of selected 
bacterial families in the majority of individuals. This is in line with the “niche-
based” bacterial community assembly proposed by Costello et al. in the context 
of the metacommunity theory 
77
. According to this theory, human beings can be 
viewed as made of several habitats suitable for bacteria, which are spatially 
distinct areas and contain each a peculiar community of microorganisms 
78
. 
In order to identify potential migration patterns from one ecosystem to the 
others, the characteristics of the OTUs shared among the three ecosystems were 
explored. Members of the families Streptococcaceae and Staphylococcaceae 
were found to be shared by at least two ecosystems in the vast majority of the 
patients; interestingly, there was a substantial identity between the 
Streptococcaceae found in the infant’s mouth and in HM. This observation, taken 
together with the very high abundance of Streptococcaceae in the infants’ 
mouth, confirms the hypothesis according to which the infant’s saliva could have 
a seeding effect, during breastfeeding, on HM microbiota. Recent data suggest 
that the interaction between HM and neonatal saliva is extremely important, not 
only for sharing beneficial bacteria, but also because it creates an unique 
synergism which boosts early innate immunity 
79
. 
In addition, the very high proportion of cases in which the same Streptococcus 
and Staphylococcus OTUs were shared by all the three ecosystems within single 
infant/mother pairs calls for some speculation about the existence of a biological 
or ecological role of these bacteria in the building of infants’ GM. Although 
sharing does not necessarily prove the direction of bacterial migration, we might 
speculate that, for these bacteria, the infant’s mouth can be the principal source 
of contamination, during breastfeeding, for both HM and the gut. 
Several OTUs assigned to the genus Bifidobacterium (B. breve, B. bifidum, B. 
longum) were shared in at least half of HM and stool samples taken from single 
infant/mother pairs: this observation supports the hypothesis of a vertical 
transfer of these bacteria via breastfeeding 
72
. In this perspective, HM acts as a 
reservoir of these bacteria, which are crucial for infant’s health since they are 
involved in the metabolism of HM oligosaccharides 
80,81
, for the infant’s GM. 
Bifidobacteriaceae were almost absent in the infant’s saliva, which was expected 
due to the unfavourable aerobic oral environment. However, thanks to their 
ability to tolerate oxygen exposure 
82
, it is plausible that Bifidobacteriaceae can 
transit safely through the oral cavity without actively colonizing it.  
To the best of our knowledge, this is the first study aiming at investigating the 
establishment of GM in a very homogeneous cohort of healthy term infants, by 
evaluating at the same time microbiota of stools, saliva, and mother’s milk. 
The characteristics of GM in term infants were similar to those described in the 
literature, with a dominance of Bifidobacteriaceae, followed by 
Enterobacteriaceae and Streptococcaceae. Interestingly, GM showed the highest 
weighted and unweighted UniFrac distances, confirming the wide interindividual 
variability in GM microbial features. On the contrary, within-samples variability 
of saliva microbiota was the lowest when the weighted UniFrac distances were 
calculated, confirming that saliva microbiota is “homogeneous” as for the 
dominance of Streptococcaceae, but very variable in terms of the other 
subdominant families. 
In the present study, the evaluation of GM establishment in term infants had two 
main limitations: the first was the absence of a maternal stool sample, which 
could have allowed a deeper evaluation of a potential entero-mammary pathway 
for some bacteria. The second was the lack of the evaluation of microbial 
changes occurring in microbiota of HM, stools and saliva during the first days of 
life.  
On the contrary, data obtained in the present study from moderately preterm 
infants are quite helpful at shedding some light over developmental microbiota 
trajectories over time.  
Recent literature, focused on the establishment of GM in both healthy term 
infants and very low birth weight infants, has highlighted significant 
dissimilarities between these two groups of infants, which can possibly impact on 
their tremendously different clinical outcome 
41
. The establishment of GM begins 
in utero in both groups. However, the shaping of GM during the first days/weeks 
of life follows two completely separate paths, as these two groups of infants 
experience very different environmental and clinical influences. Although 
moderately preterm infants do not usually have the same risk of adverse clinical 
outcomes such as infants born very preterm, they often experience mild 
gastrointestinal and pulmonary impairment, which require a few-week admission 
to the NICU and the consequently inevitable separation from the mother.   
For this reason, it is plausible that the establishment of GM in moderately 
preterm infants would be more affected by environmental factors than by the 
mutual relationship with the mother, thus resembling more the GM of more 
preterm infants. However, at present there is virtually no knowledge about the 
features of GM in moderately preterm infants. 
According to the results of the present study, microbiota from gut, saliva, and 
HM of infants born moderately preterm is different in terms of microbial 
composition compared to those of term infants.  
Specifically, at DOL 21, gut microbiota of moderately preterm infants was largely 
dominated by Enterobacteriaceae, while the contribution of Bifidobacteriaceae 
to its overall diversity was less pronounced than in term infants. Furthermore, 
GM of moderately preterm infants had a higher proportion of Clostridiaceae and 
Veillonellaceae compared to that of term infants, while Bacteroidaceae were 
almost absent. Similarly to term counterparts, in moderately preterm infants 
there was a high interindividual variability in the most abundant bacterial 
families. 
When HM microbiota data from moderately preterm infants was analysed 
regardless sampling time, there were also several substantial differences with 
term infants. Similarly to term infants’ one, HM microbiota of moderately 
preterm infants was largely dominated by Staphylococcaceae and 
Streptococcaceae. However, the relative abundance of Staphylococcaceae was 
much higher than in term infants, whereas the proportion of Bifidobacteriaceae 
was very low. There was also a lower representation of adult-gut specific 
bacteria such as Lachnospiraceae, Ruminococcaceae and Bacteroidaceae. 
Overall, these differences with term infants can be interpreted in the frame of a 
completely different environmental exposure of moderately preterm infants, 
who are generally separated from the mother at birth and admitted to the NICU.   
The separate longitudinal analysis of the two HM sets showed some similarities 
and some differences in HM microbiota development. The most interesting 
finding was that, in both sets, the relative abundance of Staphylococcaceae 
decreased, while that of Streptococcaceae increased over time. The shift 
between the dominance of Staphylococcaceae vs. Streptococcaceae appeared to 
be temporally related to the first contact of the infants with their mothers’ 
breasts. This observation seems to confirm the hypothesis according to which, 
when breastfeeding starts, the infant’s saliva can have a seeding effect of HM 
microbiota composition. The proportion of Bifidobacteriaceae in both HM sets 
remained very low during the entire sampling time, even if a discrete amount of 
Bifidobacteriaceae was found in the stools of all the three infants.  
As for saliva microbiota, this was largely dominated by members of the family 
Streptococcaceae, similarly to what is documented in term infants. However, 
these bacteria were absent from the oral cavity on DOL 1, due to the dominance 
of other bacteria of environmental origin. Saliva microbiota of all the infants also 
had a discrete representation of Micrococcaceae: the relative abundance of 
these bacteria showed a peculiar behaviour in all the infants, with a sudden 
increase at a certain sampling time, followed by a sort of plateau and a 
subsequent sudden decrease (generally at 5-6 months of life). Micrococcaceae 
are common skin inhabitants 
83
: we can speculate that the fluctuations of their 
abundance in the saliva of moderately preterm infants might be related to the 
characteristics of preterm infant feeding, which change over time. As suggested 
by data from the included infants who had the longest follow up, 
Micrococcaceae increased in saliva when infants were first breastfed; later on, 
when infants started to receive complementary feeding, and thus the contact 
with maternal skin for breastfeeding was reduced, the abundance of 
Micrococcaceae in saliva decreased dramatically.   
Beyond the common dominance of Streptococcaceae and the peculiar behaviour 
of Micrococcaceae, which were similar in all the infants, there were several 
differences in the abundance of the saliva subdominant bacterial families among 
infants, and even between twins, which could not be attributable to any known 
clinical characteristics.   
The longitudinal analysis of GM in moderately preterm infants confirmed the 
high interindividual variability of its features; in addition, the relationship of the 
characteristics of GM with oral and HM microbiota was variable and often 
unpredictable on the basis of clinical and environmental factors. Furthermore, 
Bifidobacteriaceae, which were dominant in term infants’ stools, appeared at 
very different time points in the faeces of moderately preterm infants. Despite 
the abundance of Micrococcaceae in saliva, none of the infants showed a similar 
abundance of these bacteria in stools.  
Even if the number of samples analysed so far is quite low, we can affirm that 
GM of moderately preterm infants appears to be much more similar to that of 
smaller preterm infants 
84
 than to term infants’ one, with a dominance of 
members of the family Enterobacteriaceae and other bacteria of environmental 
origin, followed lately and variably by Bifidobacteriaceae.   
These data are in accordance with the very few reports of GM analysis in 
moderately/late preterm infants: in the study by Arboleya et al. 
54
, GM of two 
moderately preterm infants was evaluated at DOL 10, showing that 
Enterobacteriaceae were the dominant bacterial family in both moderately 
preterm and VLBW infants. A single study evaluated exclusively moderately and 
late preterm infants, and focused on colonisation by Bifidobacteria 
53
. According 
to the results of that study, colonisation by members of the family 
Bifidobacteriaceae was influenced by both gestational and postmenstrual age 
and did not occur before 33 weeks corrected age. This observation was not 
confirmed by the data from the present study, where colonisation by 
Bifidobacteriaceae occurred at very different time points and without any 
apparent relationship with the abundance of these bacteria in HM or with the 
beginning of breastfeeding. 
 
Conclusions  
According to the results of the present study, we can state that microbiota from 
HM, saliva, and stools in both term and moderately preterm infants is highly 
variable and is able to adapt to the changing environment following paths which, 
at present, are quite difficult to identify. One example of this behaviour is 
probably represented by infant feeding (i.e. contact with mother’s breast, 
beginning of complementary feeding), which seems to guide a shift in microbial 
composition of HM and saliva in moderately preterm infants. We can thus 
speculate that the establishment of microbiota in infants is a dynamic process, 
specifically designed in order to adapt to the changing environmental conditions. 
The rules of this adaptation are far to be understood, but probably are guided 
primarily by the peculiar biological characteristics of each body site (mouth, 
mammary gland, gut), which tries to adapt rapidly and independently to the 
changing environment in order to maintain a microbiota as healthy as possible. 
The retrieval of a few number of bacterial families shared among term infants in 
HM can be viewed in this perspective. When adverse external stimuli prevail over 
this ability to adapt, microbiota tends towards a variable grade of dysbiosis: in 
this perspective, preterm birth disrupts, at least partially, the ability to create 
such a microbial “niche” in HM, as the preterm infant is largely exposed, in the 
first weeks of life, to several environmental stimuli (separation from the mother, 
hospital environment, drugs) which facilitate dysbiosis.  
Beyond few similarities, it is striking to note that microbiota of moderately 
preterm infants is completely different from that of term infants. The biological 
role of these differences, however, is unknown, and deserves further evaluation. 
In addition, while term infants appear to constitute a quite homogeneous group 
in terms of microbiota features, the seven moderately preterm infants analysed 
so far are extremely heterogeneous, and this heterogeneity applies also to twins 
with identical clinical and environmental exposures. We can thus speculate that 
every infant has his/her own microbiota fingerprint, and adapts the features of 
this fingerprint in his/her own peculiar way, trying to reach a delicate balance 
between positive and negative external influences.  
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